With this series, Michael Fletcher (Nature Genetics) and Simon Haas (BIH/MDC) offer insights into publishing, career talks, workshops and the chance to meet editors in person.
The James McGill Professor of Biomedical Ethics will talk about: “Clinical Trials of New Drugs: Do Patients Benefit from Participating in Clinical Trials?”
Symposium on Rare Diseases with keynotes, lectures and a panel discussion with Michael Hund (EB Research Partnership), Tobias Cantz (MHH) as well as Christopher Baum and Peter N. Robinson of the BIH.